These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23418416)

  • 1. Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus.
    van de Weijer T; Sparks LM; Phielix E; Meex RC; van Herpen NA; Hesselink MK; Schrauwen P; Schrauwen-Hinderling VB
    PLoS One; 2013; 8(2):e51648. PubMed ID: 23418416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.
    Schrauwen-Hinderling VB; Kooi ME; Hesselink MK; Jeneson JA; Backes WH; van Echteld CJ; van Engelshoven JM; Mensink M; Schrauwen P
    Diabetologia; 2007 Jan; 50(1):113-20. PubMed ID: 17093944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity.
    Meex RC; Schrauwen-Hinderling VB; Moonen-Kornips E; Schaart G; Mensink M; Phielix E; van de Weijer T; Sels JP; Schrauwen P; Hesselink MK
    Diabetes; 2010 Mar; 59(3):572-9. PubMed ID: 20028948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility.
    Chomentowski P; Coen PM; Radiková Z; Goodpaster BH; Toledo FG
    J Clin Endocrinol Metab; 2011 Feb; 96(2):494-503. PubMed ID: 21106709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in type 2 diabetes youth relates to serum free fatty acids and muscle mitochondrial dysfunction.
    Cree-Green M; Gupta A; Coe GV; Baumgartner AD; Pyle L; Reusch JE; Brown MS; Newcomer BR; Nadeau KJ
    J Diabetes Complications; 2017 Jan; 31(1):141-148. PubMed ID: 27839922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.
    Levin K; Daa Schroeder H; Alford FP; Beck-Nielsen H
    Diabetologia; 2001 Jul; 44(7):824-33. PubMed ID: 11508266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic flexibility and insulin resistance.
    Galgani JE; Moro C; Ravussin E
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1009-17. PubMed ID: 18765680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic flexibility across the spectrum of glycemic regulation in youth.
    Bacha F; Bartz SK; Puyau M; Adolph A; Sharma S
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33616083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
    Petersen KF; Dufour S; Shulman GI
    PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
    Szendroedi J; Schmid AI; Chmelik M; Toth C; Brehm A; Krssak M; Nowotny P; Wolzt M; Waldhausl W; Roden M
    PLoS Med; 2007 May; 4(5):e154. PubMed ID: 17472434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.
    Meex RC; Phielix E; Moonen-Kornips E; Schrauwen P; Hesselink MK
    J Clin Endocrinol Metab; 2011 May; 96(5):1415-23. PubMed ID: 21289240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
    Petersen KF; Dufour S; Befroy D; Garcia R; Shulman GI
    N Engl J Med; 2004 Feb; 350(7):664-71. PubMed ID: 14960743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.
    Anderwald C; Bernroider E; Krssak M; Stingl H; Brehm A; Bischof MG; Nowotny P; Roden M; Waldhäusl W
    Diabetes; 2002 Oct; 51(10):3025-32. PubMed ID: 12351443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between expression of FABPpm in skeletal muscle and insulin sensitivity in intramyocellular lipid-accumulated nonobese men.
    Kawaguchi M; Tamura Y; Kakehi S; Takeno K; Sakurai Y; Watanabe T; Funayama T; Sato F; Ikeda S; Ogura Y; Saga N; Naito H; Fujitani Y; Kanazawa A; Kawamori R; Watada H
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3343-52. PubMed ID: 24937540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of skeletal muscle mitochondrial function and lipid accumulation are moderately associated with the homeostasis model assessment index of insulin resistance in obese men.
    Samjoo IA; Safdar A; Hamadeh MJ; Glover AW; Mocellin NJ; Santana J; Little JP; Steinberg GR; Raha S; Tarnopolsky MA
    PLoS One; 2013; 8(6):e66322. PubMed ID: 23776659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study.
    Ripley EM; Clarke GD; Hamidi V; Martinez RA; Settles FD; Solis C; Deng S; Abdul-Ghani M; Tripathy D; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E229-E239. PubMed ID: 29509433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.